Subcutaneous Insulin Glargine Versus NPH Insulin in Patients With Chronic Kidney Disease Stages III and IV: Randomized Controlled Trial.
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Insulin glargine (Primary) ; Insulin suspension isophane
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 22 Aug 2019 New trial record
- 02 Aug 2019 Results published in the Clinical Therapeutics